Tretazicar T6798
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
CB1954(Tretazicar), an anticancer prodrug, is activated by NAD(P)H quinone oxidoreductase 2. It is converted in the presence of the enzyme NQO2 and co-substrate caricotamide ( EP-0152R) (EP) into a potent cytotoxic bifunctional alkylating agent.
CAS nr:
21919-05-1
Purity:
98%
Molecular Weight:
252,18
SMILES:
NC(=O)c1c(cc(c(c1)N1CC1)[N+](=O)[O-])[N+](=O)[O-]
Formula:
C9H8N4O5
Pathway:
DNA Damage/DNA Repair,DNA Damage/DNA Repair
Target:
DNA Alkylation,DNA Alkylator/Crosslinker
